ABCA3 | ATP-binding cassette, sub-family A (ABC1), member 3 | ![](/images/7884/ihc_selected_60x60.jpg) | ![](/images/7884/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/7884/23301_B_7_3_rna_selected_60x60.jpg) |
|
| Nucleus but not nucleoli Cytoplasm | Tissue enhanced | 0 |
ADAMTS8 | ADAM metallopeptidase with thrombospondin type 1 motif, 8 | ![](/images/66349/157020_A_8_5_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/66349/157019_B_8_5_rna_selected_60x60.jpg) |
|
| | Tissue enhanced | 0 |
AGBL1 | ATP/GTP binding protein-like 1 | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | |
| | Tissue enhanced | 0 |
AGRP | Agouti related neuropeptide | ![](/images/41017/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/41017/87145_B_7_7_rna_selected_60x60.jpg) |
|
| | Tissue enhanced | 0 |
ALOX15 | Arachidonate 15-lipoxygenase | ![](/images/4963/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images/4963/ihc_cell_selected_60x60.jpg) | ![](/images/13859/30913_B_2_3_rna_selected_60x60.jpg) |
|
| | Tissue enhanced | 0 |
ALPL | Alkaline phosphatase, liver/bone/kidney | ![](/images/7105/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/7105/23633_B_8_2_rna_selected_60x60.jpg) |
|
| Cytoplasm | Tissue enhanced | 0 |
ANKRD29 | Ankyrin repeat domain 29 | ![](/images/49419/ihc_selected_60x60.jpg) | ![](/images/49419/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/41272/90769_A_4_6_rna_selected_60x60.jpg) |
|
| Nucleus Vesicles | Tissue enhanced | 0 |
ATP13A4 | ATPase type 13A4 | ![](/images/51932/ihc_selected_60x60.jpg) | ![](/images/51932/1356_E9_1_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/51932/118467_B_9_3_rna_selected_60x60.jpg) |
|
| Nucleus but not nucleoli | Tissue enhanced | 0 |
BPIFA1 | BPI fold containing family A, member 1 | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/25669/59312_B_2_4_rna_selected_60x60.jpg) |
|
| | Tissue enhanced | 0 |
C1orf110 | Chromosome 1 open reading frame 110 | ![](/images/28584/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/28584/61814_B_7_5_rna_selected_60x60.jpg) |
|
| Vesicles | Tissue enhanced | 0 |
C1orf116 | Chromosome 1 open reading frame 116 | | | | ![](/images/11889/28133_B_7_5_rna_selected_60x60.jpg) |
|
| Cytoplasm Plasma membrane | Tissue enhanced | 0 |
C2orf91 | Chromosome 2 open reading frame 91 | ![](/images/42517/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/42517/92674_B_8_1_rna_selected_60x60.jpg) |
|
| | Tissue enhanced | 0 |
C5orf38 | Chromosome 5 open reading frame 38 | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | |
| | Tissue enhanced | 0 |
C6orf223 | Chromosome 6 open reading frame 223 | ![](/images/46117/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/46117/100886_B_8_6_rna_selected_60x60.jpg) | N/A |
| | Tissue enhanced | 0 |
CALCRL | Calcitonin receptor-like | ![](/images/8070/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/8070/21294_B_8_1_rna_selected_60x60.jpg) |
|
| | Tissue enhanced | 0 |
CASS4 | Cas scaffolding protein family member 4 | ![](/images/34217/121894_A_1_2_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/34217/121897_B_9_5_rna_selected_60x60.jpg) |
|
| | Tissue enhanced | 0 |
CAV1 | Caveolin 1, caveolae protein, 22kDa | | | | ![](/images/3791/10084_B_5_5_rna_selected_60x60.jpg) |
|
| Golgi apparatus | Tissue enhanced | 0 |
CAV2 | Caveolin 2 | | ![](/images/44810/if_selected_60x60.jpg) | | ![](/images/44810/109641_A_7_2_rna_selected_60x60.jpg) |
|
| Vesicles | Tissue enhanced | 0 |
CCL18 | Chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | |
| | Tissue enhanced | 0 |
CLEC14A | C-type lectin domain family 14, member A | ![](/images/39468/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/39468/86456_B_8_5_rna_selected_60x60.jpg) |
|
| | Tissue enhanced | 0 |
CLIC5 | Chloride intracellular channel 5 | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | |
| | Tissue enhanced | 0 |
COL4A3 | Collagen, type IV, alpha 3 (Goodpasture antigen) | ![](/images/42064/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/42064/90200_B_8_2_rna_selected_60x60.jpg) |
|
| Vesicles Endoplasmic reticulum | Tissue enhanced | 0 |
COL6A5 | Collagen, type VI, alpha 5 | ![](/images/43138/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/43138/93188_B_9_2_rna_selected_60x60.jpg) |
|
| | Tissue enhanced | 0 |
COL6A6 | Collagen, type VI, alpha 6 | ![](/images/45239/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/45239/99060_B_8_5_rna_selected_60x60.jpg) |
|
| | Tissue enhanced | 0 |
CPAMD8 | C3 and PZP-like, alpha-2-macroglobulin domain containing 8 | ![](/images/31327/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/31330/69390_B_7_8_rna_selected_60x60.jpg) |
|
| | Tissue enhanced | 0 |
CRTAC1 | Cartilage acidic protein 1 | ![](/images/8175/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/8175/23081_B_9_3_rna_selected_60x60.jpg) |
|
| | Tissue enhanced | 0 |
CTD-2132N18.3 | Uncharacterized protein {ECO:0000313|Ensembl:ENSP00000468275} | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | |
| | Tissue enhanced | 0 |
CTD-3214H19.16 | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | |
| | Tissue enhanced | 0 |
CXCL17 | Chemokine (C-X-C motif) ligand 17 | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | |
| | Tissue enhanced | 0 |
CYP2F1 | Cytochrome P450, family 2, subfamily F, polypeptide 1 | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | |
| | Tissue enhanced | 0 |
CYP4B1 | Cytochrome P450, family 4, subfamily B, polypeptide 1 | ![](/images/4331/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/4331/12600_A_1_5_rna_selected_60x60.jpg) |
|
| Vesicles | Tissue enhanced | 0 |
CYP4Z1 | Cytochrome P450, family 4, subfamily Z, polypeptide 1 | ![](/images/43005/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/43005/101573_B_8_6_rna_selected_60x60.jpg) |
|
| | Tissue enhanced | 0 |
DKK2 | Dickkopf WNT signaling pathway inhibitor 2 | ![](/images/9727/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/9727/33035_B_8_6_rna_selected_60x60.jpg) |
|
| | Tissue enhanced | 0 |
DNAH5 | Dynein, axonemal, heavy chain 5 | | ![](/images/37470/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/37469/73561_B_9_1_rna_selected_60x60.jpg) |
|
| Nucleus Nucleoli | Tissue enhanced | 0 |
EFCC1 | EF-hand and coiled-coil domain containing 1 | ![](/images/42798/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/42798/101414_B_9_1_rna_selected_60x60.jpg) |
|
| | Tissue enhanced | 0 |
EMP2 | Epithelial membrane protein 2 | ![](/images/14711/ihc_selected_60x60.jpg) | ![](/images/14711/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/14711/34656_B_9_2_rna_selected_60x60.jpg) |
|
| Nucleus but not nucleoli Cytoplasm | Tissue enhanced | 0 |
FAM179A | Family with sequence similarity 179, member A | ![](/images/37561/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/37561/76809_B_9_1_rna_selected_60x60.jpg) |
|
| | Tissue enhanced | 0 |
FBN3 | Fibrillin 3 | ![](/images/49482/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/49482/112661_B_9_1_rna_selected_60x60.jpg) | N/A |
| | Tissue enhanced | 0 |
FGFR4 | Fibroblast growth factor receptor 4 | ![](/images/28251/ihc_selected_60x60.jpg) | ![](/images/27273/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/27273/61123_A_1_3_rna_selected_60x60.jpg) |
|
| Nucleus but not nucleoli Cytoplasm | Tissue enhanced | 0 |
FIGF | C-fos induced growth factor (vascular endothelial growth factor D) | ![](/images/27342/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/27342/56644_B_9_1_rna_selected_60x60.jpg) |
|
| | Tissue enhanced | 0 |
FMO2 | Flavin containing monooxygenase 2 (non-functional) | ![](/images/28261/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/28261/61253_B_9_7_rna_selected_60x60.jpg) |
|
| | Tissue enhanced | 0 |
FOLR1 | Folate receptor 1 (adult) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | |
| | Tissue enhanced | 0 |
FOXA2 | Forkhead box A2 | ![](/images/1388/3096_A_5_1_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/1388/3095_B_8_1_rna_selected_60x60.jpg) |
|
| Nucleus but not nucleoli Cell Junctions | Tissue enhanced | 0 |
GDF10 | Growth differentiation factor 10 | ![](/images/15498/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/15498/35024_A_2_8_rna_selected_60x60.jpg) |
|
| | Tissue enhanced | 0 |
GPR116 | G protein-coupled receptor 116 | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | |
| | Tissue enhanced | 0 |
GPRC5A | G protein-coupled receptor, class C, group 5, member A | ![](/images/7928/155465_A_7_5_selected_60x60.jpg) | | | ![](/images/7928/155464_B_6_4_rna_selected_60x60.jpg) |
|
| Vesicles Plasma membrane | Tissue enhanced | 0 |
GPRIN2 | G protein regulated inducer of neurite outgrowth 2 | ![](/images/38129/ihc_selected_60x60.jpg) | ![](/images/38129/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/38129/130679_B_8_4_rna_selected_60x60.jpg) |
|
| Nucleus but not nucleoli | Tissue enhanced | 0 |
GRAMD2 | GRAM domain containing 2 | ![](/images/29435/ihc_selected_60x60.jpg) | ![](/images/29435/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/29435/61251_B_8_1_rna_selected_60x60.jpg) | N/A |
| Nucleus Nucleoli Cytoplasm | Tissue enhanced | 0 |
HAS3 | Hyaluronan synthase 3 | | ![](/images/33850/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/33850/69312_A_6_4_rna_selected_60x60.jpg) |
|
| Cytoskeleton (Microtubules) | Tissue enhanced | 0 |
HHIP | Hedgehog interacting protein | ![](/images/12616/ihc_selected_60x60.jpg) | ![](/images/12616/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/12616/31104_B_5_6_rna_selected_60x60.jpg) |
|
| Nucleus but not nucleoli | Tissue enhanced | 0 |